Gosun Holdings (000971.SZ) controlling shareholder has accumulated an increase of 926,100 shares of the company's stock.
Gosun Holdings (000971.SZ) announced that its controlling shareholder, Tianjin Bairuoke Pharmaceutical Biotechnology Co., Ltd. ("Tianjin Bairuoke"), has increased its holdings in the company by acquiring 926,100 shares through the Shenzhen Stock Exchange trading system. This represents 0.09% of the company's total share capital, with a total investment of RMB 1.9211 million (excluding transaction fees). The increase in holdings is part of a plan that is still ongoing, and Tianjin Bairuoke will continue to acquire more shares in accordance with the plan.
Related Articles

Cui Dongshu: By 2025, the total national second-hand car transaction volume will be 20.11 million units, an increase of 2.5% year-on-year.

Oracle’s Up-to-$50 Billion 2026 Funding Plan Signals the Next Phase of the AI Data-Center Buildout

Societe Generale Raises 2026 Profitability Target After Q4 Beat, Signals Capital Return Momentum
Cui Dongshu: By 2025, the total national second-hand car transaction volume will be 20.11 million units, an increase of 2.5% year-on-year.

Oracle’s Up-to-$50 Billion 2026 Funding Plan Signals the Next Phase of the AI Data-Center Buildout

Societe Generale Raises 2026 Profitability Target After Q4 Beat, Signals Capital Return Momentum

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


